FDA Inspection 1073855 — Reproductive Medicine Institute
The FDA completed an inspection of Reproductive Medicine Institute on November 14, 2018 in Skokie, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 14, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Skokie, IL (United States)